Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 6kWORD 18k
20 February 2018
Question for written answer E-001050-18
to the Commission
Rule 130
Julie Girling (PPE) , Sirpa Pietikäinen (PPE) , Françoise Grossetête (PPE)

 Subject:  Phasing out of animal testing
 Answer in writing 

The phasing out of animal testing for regulatory safety assessment is a priority for European citizens, the Commission and Parliament.

We have been alerted that research initiatives are facing significant delays in the validation and acceptance of alternative methods due to the failure to establish the scientific advisory body within the framework of the Joint Research Centre (namely the European Union Reference Laboratory for Alternatives to Animal Testing Scientific Advisory Committee, or ESAC).

Indeed, before alternative methods are submitted for acceptance by the OECD, they should be reviewed by ESAC.

Unfortunately, that body, which should have been renewed in 2017, has not been officially established due to a complex administrative process. We understand that the final decision should be in the hands of Vice-President Jyrki Katainen.

In the meantime, important alternatives to animal testing are blocked in their official process of acceptance by the OECD.

Could the Commission ensure that ESAC is established without any further delay?

Last updated: 6 March 2018Legal notice